PRO: osmotherapy for the treatment of acute intracranial hypertension.

Détails

ID Serval
serval:BIB_4552D4D7C0BB
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
PRO: osmotherapy for the treatment of acute intracranial hypertension.
Périodique
Journal of neurosurgical anesthesiology
Auteur⸱e⸱s
Grape S., Ravussin P.
ISSN
1537-1921 (Electronic)
ISSN-L
0898-4921
Statut éditorial
Publié
Date de publication
10/2012
Peer-reviewed
Oui
Volume
24
Numéro
4
Pages
402-406
Langue
anglais
Notes
Publication types: Journal Article ; Review
Publication Status: ppublish
Résumé
Persisting severe brain edema causes intracranial hypertension and is associated with poor patient outcome. The treatment of acute intracranial hypertension is complex and multimodal. The most important options for medical treatment include controlled ventilation and osmotherapy, maintenance of brain and body homeostasis, and sedation. Osmotherapy is recommended in all relevant guidelines. The 2 osmotic agents most frequently used are mannitol and hypertonic saline. Both reduce intracranial pressure and improve cerebral perfusion and cerebral oxygen delivery. However, hypertonic saline seems advantageous over mannitol in many situations. In multitrauma patients, hypertonic saline contributes to hemodynamic stabilization and to the prevention of secondary insults. In addition, hypertonic saline has neurohumoral and immunologic effects, which may be beneficial in cerebral resuscitation.
Mots-clé
Brain Injuries/complications, Brain Injuries/therapy, Guidelines as Topic, Humans, Hypertonic Solutions/therapeutic use, Intracranial Hypertension/drug therapy, Intracranial Hypertension/etiology, Mannitol/therapeutic use, Saline Solution, Hypertonic/therapeutic use
Pubmed
Web of science
Création de la notice
14/11/2018 12:16
Dernière modification de la notice
23/01/2024 8:19
Données d'usage